Literature DB >> 31464531

Metabolically healthy and unhealthy obesity in erectile dysfunction and male infertility.

Giulia Rastrelli1, Francesco Lotti1, Yacov Reisman2, Alessandra Sforza3, Mario Maggi1, Giovanni Corona3.   

Abstract

Introduction: Metabolically unhealthy obesity (MUHO) is the most important preventable cardiovascular (CV) risk factor. Recently, the significance of metabolically healthy obesity (MHO) as a CV risk factor has raised increasing interest. MUHO is a known risk factor for erectile dysfunction (ED); however, the effect of MHO on ED has barely been investigated. This review aims at summarizing the evidence supporting the relation of MUHO and MHO to male sexual functioning and fertility. Areas covered: An extensive Medline search on obesity and ED or male infertility was conducted to summarize the role of MUHO or MHO on male sexual dysfunction and infertility. Expert opinion: Longitudinal studies have demonstrated that MHO causes vascular damage, which is consistent with the impairment in penile blood flows found in ED subjects. In this population, MHO is a predictor of CV events. The relationship between male infertility and MUHO is currently debated and data on MHO are almost completely lacking. The only available study did not find an association between obesity classes and semen parameters. Although the andrological correlates of MHO must be better assessed, in the current state, evidence suggests that MHO does not represent a benign condition and measures for improving lifestyle are mandatory.

Entities:  

Keywords:  Obesity; erectile dysfunction; fertility; healthy obesity; semen parameters; vascular impairment

Mesh:

Year:  2019        PMID: 31464531     DOI: 10.1080/17446651.2019.1657827

Source DB:  PubMed          Journal:  Expert Rev Endocrinol Metab        ISSN: 1744-6651


  10 in total

1.  Management of male factor infertility: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS) : Endorsing Organization: Italian Society of Embryology, Reproduction, and Research (SIERR).

Authors:  A Ferlin; A E Calogero; C Krausz; F Lombardo; D Paoli; R Rago; C Scarica; M Simoni; C Foresta; V Rochira; E Sbardella; S Francavilla; G Corona
Journal:  J Endocrinol Invest       Date:  2022-01-24       Impact factor: 4.256

2.  Treatment With Cholecalciferol Leads to Increase Of Selected Semen Parameters in Young Infertile Males: Results of a 6-month Interventional Study.

Authors:  I Bartl; M Ondrušová; M Kužma; P Jackuliak; A Gažová; J Kyselovič; J Payer
Journal:  Physiol Res       Date:  2021-11-30       Impact factor: 1.881

Review 3.  Metabolic Syndrome and Reproduction.

Authors:  Francesco Lotti; Sara Marchiani; Giovanni Corona; Mario Maggi
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

4.  Cardiometabolic risk is unraveled by color Doppler ultrasound of the clitoral and uterine arteries in women consulting for sexual symptoms.

Authors:  I Scavello; E Maseroli; S Cipriani; V Di Stasi; N Verde; D Menafra; S Scannerini; S Marchiani; G Rastrelli; V Ricca; F Sorbi; M Fambrini; F Petraglia; M Maggi; Linda Vignozzi
Journal:  Sci Rep       Date:  2021-09-22       Impact factor: 4.379

5.  Upregulated IGFBP3 with Aging Is Involved in Modulating Apoptosis, Oxidative Stress, and Fibrosis: A Target of Age-Related Erectile Dysfunction.

Authors:  Daoyuan Hu; Yunlong Ge; Yubin Cui; Ke Li; Jialiang Chen; Chi Zhang; Qiwei Liu; Lizhao He; Weijun Chen; Jun Chen; Cheng Hu; Hengjun Xiao
Journal:  Oxid Med Cell Longev       Date:  2022-02-03       Impact factor: 6.543

6.  Effect of Huaji Jianpi Decoction on the semen quality of high-fat diet-induced obese mice.

Authors:  Yinling Wu; Miao Zhang; Qinglei Zhao; Lanyu Chen; Guifang Wang; Shaoqin Ge; Shusong Wang
Journal:  Transl Androl Urol       Date:  2022-03

7.  The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: Prostate-vesicular transrectal ultrasound reference ranges and associations with clinical, seminal and biochemical characteristics.

Authors:  Francesco Lotti; Francesca Frizza; Giancarlo Balercia; Arcangelo Barbonetti; Hermann M Behre; Aldo E Calogero; Jann-Frederik Cremers; Felice Francavilla; Andrea M Isidori; Sabine Kliesch; Sandro La Vignera; Andrea Lenzi; Marios Marcou; Adrian Pilatz; Olev Poolamets; Margus Punab; Maria Fernanda Peraza Godoy; Claudia Quintian; Osvaldo Rajmil; Gianmaria Salvio; Osama Shaeer; Wolfgang Weidner; Elisa Maseroli; Sarah Cipriani; Elisabetta Baldi; Selene Degl'Innocenti; Giovanna Danza; Anna Lucia Caldini; Alessandro Terreni; Luca Boni; Csilla Krausz; Mario Maggi
Journal:  Andrology       Date:  2022-07-19       Impact factor: 4.456

Review 8.  Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer.

Authors:  Giovanni Corona; Sandra Filippi; Nicola Bianchi; Mauro Dicuio; Giulia Rastrelli; Sergio Concetti; Alessandra Sforza; Mario Maggi
Journal:  World J Mens Health       Date:  2020-08-18       Impact factor: 5.400

Review 9.  The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts.

Authors:  Omer Faruk Kirlangic; Didem Yilmaz-Oral; Ecem Kaya-Sezginer; Gamze Toktanis; Aybuke Suveyda Tezgelen; Ekrem Sen; Armagan Khanam; Cetin Volkan Oztekin; Serap Gur
Journal:  Sex Med       Date:  2020-03-20       Impact factor: 2.491

Review 10.  Testosterone Deficiency and Risk of Cognitive Disorders in Aging Males.

Authors:  Giovanni Corona; Federica Guaraldi; Giulia Rastrelli; Alessandra Sforza; Mario Maggi
Journal:  World J Mens Health       Date:  2020-04-01       Impact factor: 5.400

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.